Bill Ackman also has a positive stance on Valeant
Bill Ackman is another prominent hedge fund manager. He’s the founder and CEO of Pershing Square Capital Management. He also has a positive stance on Valeant. He thinks that Valeant is simply suffering from uncertainty. It has $10 billion in non-core assets, which will likely help it increase its valuation. He’s also a board member of Valeant Pharmaceuticals (VRX). On a year-to-date basis, the stock returned -73%, while the broad market S&P 500 index (SPY) (QQQ) (VFINX) (IWM) returned 6.2% during this period.